A 12-week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of KGC11o on Prostate Gland Health

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009910

Enrollment

100

Registered

2024-11-08

Start date

2024-09-02

Completion date

Unknown

Last updated

2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : 1) Active Ingredient Name: Red Ginseng Oil (KGC11o) Appearance and Dosage Form: Dark brown soft gelatin capsule (Oval) Content: 500 mg/capsule Storage Instructions: Store in a coo

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Male with a Total IPSS (international prostate symptom score) score of 8-19

Exclusion criteria

Exclusion criteria: 1) Patients undergoing treatment for malignant tumors 2) Patients with a serum PSA concentration of 4.0 ng/mL or higher 3) Patients with a maximum urinary flow rate less than 5 mL/sec or residual urine volume exceeding 150 mL 4) Patients who had undergone prostate surgery 5) Patients with uncontrolled hypertension or diabetes 6) and any other patients whose medical condition was determined to be problematic to participate in this study

Design outcomes

Primary

Measure	Time frame
International Prostate Symptom Score, IPSS	—

Secondary

Measure	Time frame
uroflowmetry	—

Countries

Korea, Republic of

Contacts

Public ContactDongho Shin

The Catholic University of Korea, Seoul St. Mary's Hospital

eds8813@naver.com+82-2-2258-1401

Outcome results